{"id":7818,"date":"2020-09-14T00:00:00","date_gmt":"2020-09-14T00:00:00","guid":{"rendered":"https:\/\/entrepreneurs.utoronto.ca\/ip-education\/event\/level-up-leveraging-ai-for-drug-discovery-as-a-biology-startup\/"},"modified":"2021-09-09T18:30:46","modified_gmt":"2021-09-09T18:30:46","slug":"level-up-leveraging-ai-for-drug-discovery-as-a-biology-startup","status":"publish","type":"event","link":"https:\/\/entrepreneurs.utoronto.ca\/ip-education\/event\/level-up-leveraging-ai-for-drug-discovery-as-a-biology-startup\/","title":{"rendered":"Level Up: Leveraging AI for Drug Discovery as a Biology Startup"},"content":{"rendered":"\n
\n
\n event<\/a> <\/div>\n \n

Level Up: Leveraging AI for Drug Discovery as a Biology Startup<\/h2>\n\n
\n
\n
<\/div>\n
<\/div>\n
<\/div>\n <\/div> <\/div>\n \n \n<\/div>\n\n\n\n
\n \n
\n Artificial Intelligence for healthcare is here to stay. Machine learning and AI have made it possible to search and develop new pharmaceuticals, faster, cheaper, and more effectively.\n\nIf you have a biology startup, it may seem obvious to leverage the power of AI to speed up your research \u2013 but just because you can, doesn\u2019t mean you should. On October 1, two AI companies partnering with biology startups will present their views on:\n